Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mitigating Risk of COVID-19 for Clinical Management of Genitourinary Diseases

NCT04761107 is registered in ClinicalTrials.gov with Icahn School of Medicine at Mount Sinai as lead sponsor.

NCT NCT04761107
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04761107 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mitigating Risk of COVID-19 for Clinical Management of Genitourinary Diseases
Lead sponsor
Icahn School of Medicine at Mount Sinai
Phase
Observational
Overall status
Active, not recruiting
Start date
February 18, 2021
Completion date
February 28, 2026
Enrollment
15,240 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

benign urologic conditions, covid-19 infection, genitourinary cancer